secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001193125-23-166855
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agios stockholders approve 2023 Stock Incentive Plan; elect three Class I directors
--------------------------------------------------------------------------------

- Elected Rahul Ballal, Brian Goff, and Cynthia Smith as Class I directors for terms expiring at the 2026 annual meeting.
- 2023 Stock Incentive Plan approved with 27,268,226 votes for, 23,635,666 against, and 25,531 abstentions.
- Non-binding advisory vote on named executive officer compensation passed (46,289,192 for, 4,630,627 against).
- PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2023 (50,024,364 for, 1,876,012 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/0001193125-23-166855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/d415331d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-166855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer